Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillance

Tsunoda A, Mizuno T, Nakamori S, Ichikawa M, Tono Y, Saito K, Tawara I

Breast Cancer: Targets and Therapy 2026, 18:596107

Published Date: 13 April 2026